CSL Ltd - Company Profile
Powered by 
All the data and insights you need on CSL Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date CSL Ltd Strategy Report
- Understand CSL Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on CSL Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4058049A1 | Application | POLYPEPTIDE ZUR INDUKTION DER TOLERANZ GEGEN FAKTOR VIII | A61K38/00; A61K47/643; C07K14/755; C07K2319/33 | September 21, 2022 |
| EP4058426A1 | Application | EINSTUFIGE SYNTHESE VON ALKYL-2-FLUORACRYLATEN | C07C67/32 | September 21, 2022 |
| EP4054630A2 | Application | ZUSAMMENSETZUNGEN UND VERFAHREN ZUM PRODUZIEREN EINES VIRALEN VAKZINS MIT REDUZIERTER TEILCHENGRÖSSE | A61K2039/5252; A61K2039/5258; A61K39/12; A61K39/145; A61P31/12; A61P31/16; C12N2760/16011; C12N2760/16111; C12N2760/16134; C12N2760/16151; C12N2760/16211; C12N2760/16234; C12N2760/16251; C12N7/04; C12N7/06 | September 14, 2022 |
| CA2865810C | Grant | TREATMENT OF MUCOSITIS WITH IMMUNOGLOBULIN | A61P1/00; A61P1/02; A61P1/04; A61P17/02; A61P29/00; A61P31/04; A61P31/10; A61P43/00; C07K16/06; C07K16/065; C07K16/12; C07K16/1203; C07K16/14; C07K2317/21; C07K2317/76 | September 06, 2022 |
| ES2395855T5 | Grant | Factor VIII y factor de von Willebrand para el tratamiento de coagulopatías inducidas por inhibidores de los trombocitos | A61K35/13; A61K38/36; A61K38/37; A61P7/00; A61P7/02; A61P7/04 | September 06, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer